留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

儿童急性白血病合并呼吸道感染的危险因素及预防性护理措施分析

王闰平 郑小芬 陈迎秋 陈爱鹉 金芝芝 李玉嬉

王闰平, 郑小芬, 陈迎秋, 陈爱鹉, 金芝芝, 李玉嬉. 儿童急性白血病合并呼吸道感染的危险因素及预防性护理措施分析[J]. 中华全科医学, 2023, 21(3): 522-525. doi: 10.16766/j.cnki.issn.1674-4152.002922
引用本文: 王闰平, 郑小芬, 陈迎秋, 陈爱鹉, 金芝芝, 李玉嬉. 儿童急性白血病合并呼吸道感染的危险因素及预防性护理措施分析[J]. 中华全科医学, 2023, 21(3): 522-525. doi: 10.16766/j.cnki.issn.1674-4152.002922
WANG Runping, ZHENG Xiaofen, CHEN Yingqiu, CHEN Aiwu, JIN Zhizhi, LI Yuxi. Risk factors and preventive nursing measures of acute leukaemia complicated with respiratory tract infection in children[J]. Chinese Journal of General Practice, 2023, 21(3): 522-525. doi: 10.16766/j.cnki.issn.1674-4152.002922
Citation: WANG Runping, ZHENG Xiaofen, CHEN Yingqiu, CHEN Aiwu, JIN Zhizhi, LI Yuxi. Risk factors and preventive nursing measures of acute leukaemia complicated with respiratory tract infection in children[J]. Chinese Journal of General Practice, 2023, 21(3): 522-525. doi: 10.16766/j.cnki.issn.1674-4152.002922

儿童急性白血病合并呼吸道感染的危险因素及预防性护理措施分析

doi: 10.16766/j.cnki.issn.1674-4152.002922
基金项目: 

浙江省基础公益研究计划项目 GF21G020006

温州市科研项目 Y2020458

详细信息
    通讯作者:

    郑小芬,E-mail: 3297353162@qq.com

  • 中图分类号: R725.5 R473.55

Risk factors and preventive nursing measures of acute leukaemia complicated with respiratory tract infection in children

  • 摘要:   目的  对儿童急性白血病(AL)合并呼吸道感染的危险因素进行分析,通过结果提出预防护理措施,为临床治疗提供参考。  方法  回顾性分析2018年2月—2021年2月温州医科大学附属第二医院收治的140例儿童AL患者,分为呼吸道感染组(72例)和非呼吸道感染组(68例)。收集患者的相关临床资料,分析影响儿童AL合并呼吸道感染的危险因素,并提出预防性护理措施。  结果  重度贫血、白细胞计数>10×109/L或<2×109/L、血小板<20×109/L、低蛋白血症、住院时间延长、化疗方案、预防性应用抗生素是儿童白血病合并呼吸道感染的影响因素(均P<0.05);多因素logistic回归分析显示重度贫血(OR=2.440, 95% CI:1.073~5.546)、血小板<20×109/L(OR=1.972, 95% CI:1.061~3.663)、低蛋白血症(OR=2.959, 95% CI:1.115~7.853)、IA化疗方案(OR=3.799, 95% CI:1.207~11.957)是影响儿童AL合并呼吸道感染的独立危险因素。  结论  儿童AL合并呼吸道感染的危险因素包括重度贫血、血小板<20×109/L、低蛋白血症、IA化疗方案,临床需针对上述危险因素采取预防性护理措施。

     

  • 表  1  影响儿童AL合并呼吸道感染的单因素分析

    Table  1.   Univariate analysis of factors affecting respiratory infections in children with AL

    组别 例数 性别[例(%)] 年龄(x±s,岁) 血红蛋白[例(%)] 白细胞计数[例(%)]
    <60 g/L ≥60 g/L (2~10)×109/L >10×109/L或<2×109/L
    呼吸道感染组 72 41(56.94) 31(43.06) 8.45±1.58 49(68.06) 23(31.94) 15(20.83) 57(79.17)
    非呼吸道感染组 68 40(58.82) 28(41.18) 8.21±1.73 29(42.65) 39(57.35) 29(42.65) 39(57.35)
    统计量 0.051a 0.858b 9.150a 7.722a
    P 0.822 0.392 0.002 0.005
    组别 例数 血小板计数[例(%)] 低蛋白血症[例(%)] 化疗方案[例(%)] 住院时间(x±s,d)
    <30×109/L ≥30×109/L IA化疗 DA化疗
    呼吸道感染组 72 59(81.94) 13(18.06) 52(72.22) 20(27.78) 39(54.17) 33(45.83) 32.26±3.84
    非呼吸道感染组 68 35(51.47) 33(48.53) 27(39.71) 41(60.29) 19(27.94) 49(72.06) 28.53±3.95
    统计量 14.721a 15.039a 9.912a 4.146b
    P <0.001 <0.001 0.002 <0.001
    组别 例数 预防性抗生素[例(%)] 淋巴细胞计数[例(%)] 骨髓增生程度[例(%)] 是否PICC[例(%)]
    >0.5×109/L ≤0.5×109/L 活跃 一般或降低
    呼吸道感染组 72 29(40.28) 43(59.72) 28(38.89) 44(61.11) 51(70.83) 21(29.17) 49(68.06) 23(31.94)
    非呼吸道感染组 68 40(58.82) 28(41.18) 31(45.58) 37(54.42) 45(66.18) 23(33.82) 42(61.76) 26(38.24)
    统计量 4.812a 0.644a 0.352a 0.608a
    P 0.028 0.422 0.553 0.435
    注:IA为去甲氧柔红霉素联合阿糖胞苷;DA为柔红霉素联合阿糖胞苷;PICC为经外周静脉行中心静脉置管。a为χ2值,bt值。
    下载: 导出CSV

    表  2  变量赋值方法

    Table  2.   Variable assignment methods

    变量 赋值方法
    血红蛋白(g/L) <60=1,≥60=2
    白细胞计数(×109/L) 2~10=1,>10或<2=2
    血小板计数(×109/L) <30=1,≥30=2
    低蛋白血症 无=1,有=2
    住院时间(d) 以实际值赋值
    化疗方案 IA化疗=1,DA化疗=2
    预防性使用抗生素 无=1,有=2
    是否合并呼吸道感染 否=1,是=2
    下载: 导出CSV

    表  3  儿童AL合并呼吸道感染的多因素logistic回归分析

    Table  3.   Multivariate logistic regression analysis of children with AL complicated with respiratory infections

    项目 B SE Wald χ2 P OR 95% CI
    重度贫血 0.892 0.419 9.982 0.002 2.440 1.073~5.546
    白细胞>2及<10(×109/L) 0.436 0.286 3.192 0.074 1.546 0.883~2.709
    血小板<20×109/L 0.679 0.316 7.998 0.005 1.972 1.061~3.663
    低蛋白血症 1.085 0.498 13.686 < 0.001 2.959 1.115~7.853
    IA化疗方案 1.335 0.585 14.979 < 0.001 3.799 1.207~11.957
    住院时间 0.415 0.276 2.889 0.089 1.514 0.882~2.601
    预防性使用抗生素 0.453 0.293 1.896 0.169 1.573 0.886~2.793
    下载: 导出CSV
  • [1] 张培芬. 儿童急性淋巴细胞白血病化疗后合并肺部感染的临床特征[D]. 广州: 南方医科大学, 2018.

    ZHANG P F. Clinical features of pulmonary infection in children with acute lymphoblastic leukemia after chemotherapy[D]. Guangzhou: Southern Medical University, 2018.
    [2] 衣晓丽, 刘晓明, 刘天峰, 等. CCLG-ALL2008方案治疗303例儿童ALL诱导期感染并发症分析[J]. 中国小儿血液与肿瘤杂志, 2017, 22(6): 286-291. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXY201706003.htm

    YI X L, LIU X M, LIU T F, et al. Infections during induction therapy in 339 Children with Acute Lymphoblastic Leukemia treated with CCLG-2008 protocol[J]. Journal of China Pediatric Blood and Cancer, 2017, 22(6): 286-291. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXY201706003.htm
    [3] 李岩, 肖晓光, 林琳, 等. 急性白血病患者合并感染的菌群分布及耐药性分析[J]. 国际检验医学杂志, 2017, 38(3): 339-341. https://www.cnki.com.cn/Article/CJFDTOTAL-GWSQ201703020.htm

    LI Y, XIAO X G, LIN L, et al. Analysis on bacterial flora distribution and drug resistance in patients with acute leukemia complicating infection[J]. International Journal of Laboratory Medicine, 2017, 38(3): 339-341. https://www.cnki.com.cn/Article/CJFDTOTAL-GWSQ201703020.htm
    [4] 程英英, 胡萌, 杨海平. 观察儿童急性白血病化疗后肺部感染的临床特点、影像学表现及治疗效果[J]. 包头医学院学报, 2020, 36(9): 41-44. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX202009012.htm

    CHENG Y Y, HU M, YANG H P. The clinical features, imaging manifestations and therapeutic effects of lung infections in children with acute leukemia after chemotherapy[J]. Journal of Baotou Medical College, 2020, 36(9): 41-44. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX202009012.htm
    [5] 王静, 章樱. 儿童呼吸道感染的临床特征、预后及其影响因素分析[J]. 中华全科医学, 2021, 19(2): 245-247. doi: 10.16766/j.cnki.issn.1674-4152.001778

    WANG J, ZHANG Y. Analysis of clinical features, prognosis and influencing factors of respiratory tract infection in children[J]. Chinese Journal of General Practice, 2021, 19(2): 245-247. doi: 10.16766/j.cnki.issn.1674-4152.001778
    [6] 李妍, 史爱华. 急性白血病化疗后下呼吸道感染病原菌分布及耐药性分析[J]. 临床和实验医学杂志, 2018, 17(5): 548-550. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLC201805030.htm

    LI Y, SHI A H. The distribution of pathogenic bacteria and drug resistance of lower respiratory tract infection after chemotherapy of acute leukemia[J]. Journal of Clinical and Experimental Medicine, 2018, 17(5): 548-550. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLC201805030.htm
    [7] 孙珠君, 屈蕾, 杨肖肖. 儿童急性白血病合并呼吸道感染的危险因素及预防性护理干预分析[J]. 中国肿瘤临床与康复, 2018, 25(9): 1123-1125. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZK201809028.htm

    SUN Z J, QU L, YANG X X. Risk factors and preventive nursing intervention for acute leukemia complicated with respiratory tract infection in children[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2018, 25(9): 1123-1125. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZK201809028.htm
    [8] 王环. 急性白血病化疗后肺部感染患者的证型及危险因素分析[D]. 广州: 广州中医药大学, 2019.

    WANG H. Analysis of syndrome types and risk factors of pulmonary infection in patients with acute leukemia after chemotherapy[D]. Guangzhou: Guangzhou University of Traditional Chinese Medicine, 2019.
    [9] 袁萍, 张睿, 陈斗佳, 等. 急性髓系白血病诱导缓解期患者下呼吸道感染的危险因素分析[J]. 中华医院感染学杂志, 2017, 27(20): 4637-4640. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201720021.htm

    YUAN P, ZHANG R, CHEN D J, et al. Risk factors of nosocomial lower respiratory tract infections in patients with acute myeloid leukemia during remission period[J]. Chinese Journal of Nosocomiology, 2017, 27(20): 4637-4640. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201720021.htm
    [10] 杨晓阳, 蔡耘, 林丽敏, 等. 儿童急性白血病化学治疗后医院感染的危险因素及病原体分析[J]. 新医学, 2018, 49(11): 798-802. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXX201811006.htm

    YANG X Y, CAI Y, LIN L M, et al. Risk factors and pathogen analysis of nosocomial infection in children with acute leukemia after chemotherapy[J]. Journal of New Medicine, 2018, 49(11): 798-802. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXX201811006.htm
    [11] 赵美淑. 老年急性髓系白血病化疗后医院感染特点及危险因素分析[D]. 昆明: 昆明医科大学, 2019.

    ZHAO M S. Characteristics and risk factors of nosocomial infection in elderly patients with acute myeloid leukemia after chemotherapy[D]. Kunming: Kunming Medical University, 2019.
    [12] 黄璟, 李静, 何志旭, 等. 急性淋巴细胞白血病患儿在诱导缓解期的营养不良状况调查[J]. 中国肿瘤临床, 2018, 45(21): 1096-1099. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL201821005.htm

    HUANG J, LI J, HE Z X, et al. Analysis of malnutrition status in pediatric acute lymphoblastic leukemia patients during the induced remission stage[J]. Chinese Journal of Clinical Oncology, 2018, 45(21): 1096-1099. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL201821005.htm
    [13] 唐秋元. 初治非M3型AML经IA方案和DA方案诱导缓解治疗的临床疗效及不良反应对比[J]. 云南医药, 2019, 40(3): 243-245. https://www.cnki.com.cn/Article/CJFDTOTAL-YNYY201903017.htm

    TANG Q Y. To compare the clinical efficacy and adverse reactions of IA regimen and DA regimen in induction remission treatment of newly diagnosed non-M3 AML[J]. Medicine and Pharmacy of Yunnan, 2019, 40(3): 243-245. https://www.cnki.com.cn/Article/CJFDTOTAL-YNYY201903017.htm
    [14] 罗姗. 剂量调整的DA与IA方案诱导化疗成人AML疗效及安全性的比较[D]. 成都: 成都医学院, 2018.

    LUO S. Comparison of efficacy and safety of dose-adjusted DA and IA regimen as induction chemotherapy in adult AML patients[D]. Chengdu: Chengdu Medical College, 2018.
    [15] 唐晶, 张荣, 李冬梅. 急性髓系白血病患者化疗后院内感染危险因素及护理措施分析[J]. 现代医学, 2020, 48(11): 1448-1451. https://www.cnki.com.cn/Article/CJFDTOTAL-TDYX202011020.htm

    TANG J, ZHANG R, LI D M. Analysis of risk factors and nursing measures of nosocomial infection in patients with acute myeloid leukemia after chemotherapy[J]. Modern Medical Journal, 2020, 48(11): 1448-1451. https://www.cnki.com.cn/Article/CJFDTOTAL-TDYX202011020.htm
  • 加载中
表(3)
计量
  • 文章访问数:  212
  • HTML全文浏览量:  84
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-05-11
  • 网络出版日期:  2023-04-19

目录

    /

    返回文章
    返回